New Moderna agreement will double vaccine drug substance production at Visp, says Lonza
Three additional drug substance manufacturing lines will be added to existing ones at Swiss site and are expected to be operational in early 2022
CDMO Lonza says it will double drug substance production of Moderna’s mRNA COVID-19 vaccine at its Visp site in Switzerland, after expanding its existing manufacturing agreement with the US biotech.
The deal paves the way for the installation of three additional drug substance manufacturing lines with equivalent capacities to existing lines at Visp, which are expected to be operational in early 2022.
“We have commenced and ramped up operations in our four existing production lines at an unprecedented rate and scale,” said Lonza CEO, Pierre-Alain Ruffieux. “Our new agreement with Moderna will double our drug substance manufacturing capacity in Visp, at this time of urgent global demand.”
Lonza said the new lines will be built at its Ibex Solutions facility, alongside the existing production lines for the Moderna vaccine.
The CDMO added that recruitment for the additional lines has already begun as part of wider recruitment efforts – including tapping the international market -- to support expansion plans at the Visp facility, including the recently announced construction of a new small molecule manufacturing complex.
Earlier this week Reuters reported that in a bid to speed up operations, Lonza is recruiting temporary employees from food company Nestle to staff Switzerland-based plants making ingredients for the Moderna vaccine, citing state broadcaster RTS.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance